Immunohistochemical analyses revealed that the number of proliferating cell nuclear antigen (PCNA)-positive tumour cells was significantly reduced in Yamato-SS xenograft tumours treated with TAS-115 (Fig. 6c, d). Here, PCNA is linked to neoplasm.